Zhejiang Yatai Pharmaceutical (SZSE:002370 Shareholders Incur Further Losses as Stock Declines 15% This Week, Taking Five-year Losses to 47%

Simply Wall StDec 23, 2024 23:33 ET

Zhejiang Yatai Pharmaceutical's Diltiazem Hydrochloride Tablets Enter Consistency Evaluation Review Stage

MT NewswiresNov 29, 2024 01:25 ET

Optimistic Investors Push Zhejiang Yatai Pharmaceutical Co., Ltd. (SZSE:002370) Shares Up 29% But Growth Is Lacking

Simply Wall StAug 16, 2024 19:17 ET

Some Zhejiang Yatai Pharmaceutical Co., Ltd. (SZSE:002370) Shareholders Look For Exit As Shares Take 26% Pounding

Simply Wall StFeb 2, 2024 17:44 ET

Further Weakness as Zhejiang Yatai Pharmaceutical (SZSE:002370) Drops 14% This Week, Taking Five-year Losses to 67%

Simply Wall StAug 22, 2023 18:27 ET

Court Orders Bankruptcy Liquidation of Yatai Pharma Unit

MT NewswiresJun 19, 2023 06:37 ET